Research Article

High Intensity Interval Training Favourably Affects Angiotensinogen mRNA Expression and Markers of Cardiorenal Health in a Rat Model of Early-Stage Chronic Kidney Disease

Table 2

Primer sequences.

TargetPrimer sequence (5′-3′)

Angiotensin I converting enzyme (Ace) forward CTTGACCCTGGATTGCAGCC
Angiotensin I converting enzyme (Ace) reverse GTTTCGTGAGGAAGCCAGGA
Angiotensin II receptor, type 1a (Agtr1a) forward AGTCCTGTTCCACCCGATCA
Angiotensin II receptor, type 1a (Agtr1a) reverse TCCAGACAAAATGCCAGCCA
Angiotensin II receptor, type 1b (Agtr1b) forward ACTGCACACGGTGCATTTTA
Angiotensin II receptor, type 1b (Agtr1b) reverse TAATTGTGCCTGCCAGCCTT
Angiotensinogen (serpin peptidase inhibitor, clade A, member 8) (Agt) forward CTGGAGCTAAAGGACACACAGA
Angiotensinogen (serpin peptidase inhibitor, clade A, member 8) (Agt) reverse GTGAAGGGACCCAAGCTCTC
Cytochrome P450, family 11, subfamily b, polypeptide 2 (Cyp11b2) forward TAACTCAGGGAGCTTTACCTCT
Cytochrome P450, family 11, subfamily b, polypeptide 2 (Cyp11b2) reverse CTGAGACCCTTTGAAGGCCG
Renin (Ren) forward CCGTGGTCCTCACCAACTAC
Renin (Ren) reverse CTTGGCCAGCATGAAGGGTA
Glyceraldehyde-3-phosphate dehydrogenase (Gapdh) forward GTTACCAGGGCTGCCTTCTC
Glyceraldehyde-3-phosphate dehydrogenase (Gapdh) reverse GATGGTGATGGGTTTCCCGT